Selectivity of aggregation-determining interactions

Journal of Molecular Biology

Volumn 427, Issue 2, 2015, Pages 236-247

  Ganesan, Ashok ^a,c   Debulpaep, Maja ^a,b   Wilkinson, Hannah ^a,c   Van Durme, Joost ^a,b   De Baets, Greet ^a,c   Jonckheere, Wim ^a,b   Ramakers, Meine ^a,c   Ivarsson, Ylva ^c,d   Zimmermann, Pascale ^c   Van Eldere, Johan ^c   Schymkowitz, Joost ^a,c   Rousseau, Frederic ^a,c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Amyloid; Detection; Interaction; Protein aggregation; Specificity

Indexed keywords

BETA GALACTOSIDE; BIOTIN; C REACTIVE PROTEIN; PROSTATE SPECIFIC ANTIGEN; BACTERIAL PROTEIN; BETA GALACTOSIDASE; CHAPERONE; PEPTIDE; PROTEIN AGGREGATE; PROTEIN BINDING; PROTEOME;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; CELL LYSATE; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SEMINAL PLASMA; SERUM; WESTERN BLOTTING; BLOOD; GENETICS; INFRARED SPECTROSCOPY; MALE; METABOLISM; PROCEDURES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

BACTERIAL PROTEINS; BETA-GALACTOSIDASE; C-REACTIVE PROTEIN; ESCHERICHIA COLI; HUMANS; MALE; MOLECULAR CHAPERONES; PEPTIDES; PROSTATE-SPECIFIC ANTIGEN; PROTEIN AGGREGATES; PROTEIN BINDING; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84920836759     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2014.09.027     Document Type: Article

References (35)

1. Beerten J, Schymkowitz J, Rousseau F. Aggregation prone regions and gatekeeping residues in protein sequences. Curr Top Med Chem 2013;12:2470-8.
2. Goldschmidt L, Teng PK, Riek R, Eisenberg D. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Natl Acad Sci USA 2010;107:3487-92.
3. Esteras-Chopo A, Serrano L, de la Paz ML. The amyloid stretch hypothesis: recruiting proteins toward the dark side. Proc Natl Acad Sci USA 2005;102:16672-7.
4. Ventura S, Zurdo J, Narayanan S, Parreno M, Mangues R, Reif B, et al. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci USA 2004;101:7258-63.
5. Teng PK, Eisenberg D. Short protein segments can drive a non-fibrillizing protein into the amyloid state. Protein Eng Des Sel 2009;22:531-6.
6. Krebs MR, Morozova-Roche LA, Daniel K, Robinson CV, Dobson CM. Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci 2004;13:1933-8.
7. Xu J, Reumers J, Couceiro JR, DeSmet F, Gallardo R, Rudyak S, et al. Gain of function of mutant p53 by coaggregation with multiple tumor suppressors. Nat Chem Biol 2011;7:285-95.
8. Sabate R, Espargaro A, de Groot NS, Valle-Delgado JJ, Fernandez-Busquets X, Ventura S. The role of protein sequence and amino acid composition in amyloid formation: scrambling and backward reading of IAPP amyloid fibrils. J Mol Biol 2010;404:337-52.
9. Morell M, Bravo R, Espargaro A, Sisquella X, Aviles FX, Fernandez-Busquets X, et al. Inclusion bodies: specificity in their aggregation process and amyloid-like structure. Biochim Biophys Acta Mol Cell Res 2008;1783:1815-25.
10. Morris KL, Rodger A, Hicks MR, Debulpaep M, Schymkowitz J, Rousseau F, et al. Exploring the sequence-structure relationship for amyloid peptides. Biochem J 2013;450:275-83.
11. Makin OS, Atkins E, Sikorski P, Johansson J, Serpell LC. Molecular basis for amyloid fibril formation and stability. Proc Natl Acad Sci USA 2005;102:315-20.
12. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 2007;447:453-7.
13. Balbirnie M, Grothe R, Eisenberg DS. An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid. Proc Natl Acad Sci USA 2001;98:2375-80.
14. Chien P, DePace AH, Collins SR, Weissman JS. Generation of prion transmission barriers by mutational control of amyloid conformations. Nature 2003;424:948-51.
15. Ono K, Takahashi R, Ikeda T, Yamada M. Cross-seeding effects of amyloid beta-protein and alpha-synuclein. J Neurochem 2012;122:883-90.
16. Esteras-Chopo A, Pastor MT, Serrano L, de la Paz ML. New strategy for the generation of specific D-peptide amyloid inhibitors. J Mol Biol 2008;377:1372-81.
17. Sievers SA, Karanicolas J, Chang HW, Zhao A, Jiang L, Zirafi O, et al. Structure-based design of non-natural aminoacid inhibitors of amyloid fibril formation. Nature 2011;475:96-100.
18. Ladiwala AR, Bhattacharya M, Perchiacca JM, Cao P, Raleigh DP, Abedini A, et al. Rational design of potent domain antibody inhibitors of amyloid fibril assembly. Proc Natl Acad Sci USA 2012;109:19965-70.
19. Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013;501:45-51.
20. Eisenberg D, Jucker M. The amyloid state of proteins in human diseases. Cell 2012;148:1188-203.
21. Rousseau F, Serrano L, Schymkowitz JWH. How evolutionary pressure against protein aggregation shaped chaperone specificity. J Mol Biol 2006;355:1037-47.
22. Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 2004;22:1302-6.
23. Reumers J, Maurer-Stroh S, Schymkowitz J, Rousseau F. Protein sequences encode safeguards against aggregation. Hum Mutat 2009;30:431-7.
24. Richardson JS, Richardson DC. Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci USA 2002;99:2754-9.
25. Cannon MJ, Williams AD, Wetzel R, Myszka DG. Kinetic analysis of beta-amyloid fibril elongation. Anal Biochem 2004;328:67-75.
26. Gewurz H, Mold C, Siegel J, Fiedel B. C-reactive protein and the acute phase response. Adv Intern Med 1982;27:345-72.
27. Balk SP, Ko YJ, Bubley GJ. Biology of prostate-specific antigen. J Clin Oncol 2003;21:383-91.
28. Tyedmers J, Mogk A, Bukau B. Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol 2010;11:777-88.
29. Morimoto RI. The heat shock response: systems biology of proteotoxic stress in aging and disease. Cold Spring Harbor Symp Quant Biol 2011;76:91-9.
30. Ben-Zvi A, Miller EA, Morimoto RI. Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci USA 2009;106:14914-9.
31. Gidalevitz T, Krupinski T, Garcia S, Morimoto RI. Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLoS Genet 2009;5:e1000399.
32. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome systemby protein aggregation. Science 2001;292:1552-5.
33. Gidalevitz T, Kikis EA, Morimoto RI. A cellular perspective on conformational disease: the role of genetic background and proteostasis networks. Curr Opin Struct Biol 2010;20:23-32.
34. Ganesan A, Watkinson A, Moore BD. Biophysical characterisation of thermal-induced precipitates of recombinant anthrax protective antigen: evidence for kinetically trapped unfolding domains in solid-state. Eur J Pharm Biopharm 2012;82:475-84.
35. UniProt C. The universal protein resource (UniProt). Nucleic Acids Res 2008;36:D190-5.